P & G Health Ltd

58
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,670.25
-61.05 (-1.07%)
BSENSE

Aug 28, 03:30 PM

BSE+NSE Vol: 12.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Jun'24
Jun'23
Jun'22
Jun'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025

Compare Profit and Loss Results of P & G Health Ltd
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,407.00
947.00
460.00
48.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,407.00
947.00
460.00
48.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
47.00
-59.00
-125.53%
Raw Materials Consumed
377.00
388.00
-11.00
-2.84%
Power & Fuel Cost
7.00
25.00
-18.00
-72.00%
Employee Cost
222.00
73.00
149.00
204.11%
Operating Expenses
90.00
47.00
43.00
91.49%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
106.00
32.00
74.00
231.25%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
21.00
22.00
-1.00
-4.55%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
951.00
653.00
298.00
45.64%
Operating Profit (PBDIT) excl Other Income
456.00
294.00
162.00
55.10%
Other Income
17.00
68.00
-51.00
-75.00%
Operating Profit (PBDIT)
474.00
362.00
112.00
30.94%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
473.00
356.00
117.00
32.87%
Depreciation
23.00
24.00
-1.00
-4.17%
Profit Before Taxation & Exceptional Items
449.00
332.00
117.00
35.24%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
449.00
332.00
117.00
35.24%
Provision for Tax
122.00
84.00
38.00
45.24%
Profit After Tax
326.00
247.00
79.00
31.98%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
159.00
1,098.00
-939.00
-85.52%
Profit Available for appropriations
486.00
1,346.00
-860.00
-63.89%
Appropriations
486.00
1,346.00
-860.00
-63.89%
Equity Dividend (%)
2050%
60%
1,990.00
Earnings Per Share
197
14.29
182.71
1,278.59%
Profit And Loss - Net Sales
Net Sales 1,407.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 456.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025

Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 326.91 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025